IE
CLPT icon

Israel Englander’s ClearPoint Neuro CLPT Stock Holding History

Israel Englander’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$933K Buy
+52,300
New +$653K ﹤0.01% 4351

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Israel Englander's CLPT Position: Q2 2026 in Review

Israel Englander increased its ClearPoint Neuro (CLPT) stake by 54% in Q2 2026, buying an estimated $1.57M and bringing the position to 357,676 shares worth $6.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2761.

Israel Englander first reported a position in CLPT in Q3 2019 and has held it in 23 quarters since. The position peaked at $8.81M in Q1 2025. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Israel Englander held 357,676 shares of ClearPoint Neuro worth $6.38M as of Q2 2026.
  • Israel Englander bought 125,702 ClearPoint Neuro shares in Q2 2026, an estimated $1.57M.
  • ClearPoint Neuro made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2761 holding.
  • Israel Englander first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 23 quarters since.
  • Israel Englander's ClearPoint Neuro position peaked at $8.81M in Q1 2025.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.